Nuclear grade and comedo necrosis of ductal carcinoma in situ as histopathological eligible criteria for the Japan Clinical Oncology Group 1505 trial: an interobserver agreement study. (8th January 2021)
- Record Type:
- Journal Article
- Title:
- Nuclear grade and comedo necrosis of ductal carcinoma in situ as histopathological eligible criteria for the Japan Clinical Oncology Group 1505 trial: an interobserver agreement study. (8th January 2021)
- Main Title:
- Nuclear grade and comedo necrosis of ductal carcinoma in situ as histopathological eligible criteria for the Japan Clinical Oncology Group 1505 trial: an interobserver agreement study
- Authors:
- Tsuda, Hitoshi
Yoshida, Masayuki
Akiyama, Futoshi
Ohi, Yasuyo
Kinowaki, Keiichi
Kumaki, Nobue
Kondo, Yuzuru
Saito, Akihisa
Sasaki, Eiichi
Nishimura, Rieko
Fujii, Satoshi
Homma, Keiichi
Horii, Rie
Murata, Yuya
Itami, Makiko
Kajita, Sabine
Kato, Hiroyuki
Kurosumi, Masafumi
Sakatani, Takashi
Shimizu, Shigeki
Taniguchi, Kohei
Tamiya, Sadafumi
Nakamura, Harumi
Kanbayashi, Chizuko
Shien, Tadahiko
Iwata, Hiroji - Abstract:
- Abstract: Objective: The Japan Clinical Oncology Group 1505 trial is a single-arm multicentre prospective study that examined the possibility of non-surgical follow-up with endocrine therapy for patients with low-grade ductal carcinoma in situ . In that study, the eligible criteria included histopathological findings comprising low to intermediate nuclear grade and absence of comedo necrosis, and cases were entered according to the local histopathological diagnosis. Nuclear grade is largely based on the Consensus Conference criteria (1997), whereas comedo necrosis is judged according to the Rosen's criteria (2017). The purpose of this study was to standardize and examine the interobserver agreement levels of these histopathological criteria amongst the participating pathologists. Methods: We held slide conferences, where photomicrographs of haematoxylin–eosin-stained slides from 68 patients with ductal carcinoma in situ were presented using PowerPoint. The nuclear grade and comedo necrosis statuses individually judged by the pathologists were analysed using κ statistics. Results: In the first and second sessions, where 22 cases each were presented, the interobserver agreement levels of nuclear grade whether low/intermediate grade or high grade were moderate amongst 29 and 24 participating pathologists, respectively (κ = 0.595 and 0.519, respectively). In the third session where 24 cases were presented, interobserver agreement levels of comedo necrosis or non-comedo necrosisAbstract: Objective: The Japan Clinical Oncology Group 1505 trial is a single-arm multicentre prospective study that examined the possibility of non-surgical follow-up with endocrine therapy for patients with low-grade ductal carcinoma in situ . In that study, the eligible criteria included histopathological findings comprising low to intermediate nuclear grade and absence of comedo necrosis, and cases were entered according to the local histopathological diagnosis. Nuclear grade is largely based on the Consensus Conference criteria (1997), whereas comedo necrosis is judged according to the Rosen's criteria (2017). The purpose of this study was to standardize and examine the interobserver agreement levels of these histopathological criteria amongst the participating pathologists. Methods: We held slide conferences, where photomicrographs of haematoxylin–eosin-stained slides from 68 patients with ductal carcinoma in situ were presented using PowerPoint. The nuclear grade and comedo necrosis statuses individually judged by the pathologists were analysed using κ statistics. Results: In the first and second sessions, where 22 cases each were presented, the interobserver agreement levels of nuclear grade whether low/intermediate grade or high grade were moderate amongst 29 and 24 participating pathologists, respectively (κ = 0.595 and 0.519, respectively). In the third session where 24 cases were presented, interobserver agreement levels of comedo necrosis or non-comedo necrosis were substantial amongst 25 participating pathologists (κ = 0.753). Conclusion: Although the concordance rates in nuclear grade or comedo necrosis were not high in a few of the cases, we believe that these results could provide a rationale for employing the present criteria of nuclear grade and comedo necrosis in the clinical study of ductal carcinoma in situ . Abstract : The interobserver agreement levels of these histological criteria of nuclear grade and comedo necrosis that are employed for case entry in a clinical trial were moderate to substantial amongst pathologists. … (more)
- Is Part Of:
- Japanese journal of clinical oncology. Volume 51:Number 3(2021)
- Journal:
- Japanese journal of clinical oncology
- Issue:
- Volume 51:Number 3(2021)
- Issue Display:
- Volume 51, Issue 3 (2021)
- Year:
- 2021
- Volume:
- 51
- Issue:
- 3
- Issue Sort Value:
- 2021-0051-0003-0000
- Page Start:
- 434
- Page End:
- 443
- Publication Date:
- 2021-01-08
- Subjects:
- ductal carcinoma in situ -- nuclear grade -- comedo necrosis -- interobserver agreement
Oncology -- Periodicals
Cancer -- Periodicals
616.994005 - Journal URLs:
- http://jjco.oupjournals.org/ ↗
http://ukcatalogue.oup.com/ ↗ - DOI:
- 10.1093/jjco/hyaa235 ↗
- Languages:
- English
- ISSNs:
- 0368-2811
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4651.378000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 17087.xml